Skip to content

BETAPLUS PHARMA

Active
Public limited company·Vervaardiging van farmaceutische grondstoffen· 23 yrs active
Hippokrateslaan 10 ·1200 Sint-Lambrechts-Woluwe, Belgium
BE 0479.037.369
Watch Print / PDF

Lifecycle & Insolvency Signals

0 events from the State Gazette
No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad — acts

37 acts
All acts · 37 updated 2 months ago
2026
09-04-2026 1 director appointed, 1 resigning Director changes
  • Vianney Battle — Bestuurder
  • Benoit Woessmer — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Vianney Battle",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA"
  }
}
09-04-2026 4 directors appointed, 1 resigning Director changes
  • Vianney Battle — Bestuurder
  • Anja Seitz — Dagelijks bestuur
  • Alexis Wochenmarkt — Dagelijks bestuur
  • Emmanuel Georgas — Dagelijks bestuur
  • Benoit Woessmer — Bestuurder
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend acte de la d\u00E9mission de Monsieur Benoit Woessmer de son poste d\u0027administrateur",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": "18CE 18079",
        "name": "Vianney Battle",
        "address": "Olympiaplein 55, 1077CN, Amsterdam, Pays-bas",
        "birth_date": "1976-03-24",
        "profession": null,
        "birth_place": "Metz, France"
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9, avec effet \u00E0 la date de pr\u00E9sente r\u00E9union et pour une dur\u00E9e ind\u00E9termin\u00E9e, Monsieur Vianney Battle",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_provisional",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale donne d\u00E9charge provisoire \u00E0 Monsieur Benoit Woessmer pour l\u0027ex\u00E9cution de son mandat durant l\u0027exercice \u00E9coul\u00E9.",
      "decharge_status": "provisional",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Anja Seitz",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Thales Brussels SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e donne mandat \u00E0 Madame Anja Seitz, ou les avocats de la soci\u00E9t\u00E9 Thales Brussels SRL, dont Me Alexis Wochenmarkt, ou Emmanuel Georgas chacun pouvant agir seul et avec pouvoir de substitution",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Alexis Wochenmarkt",
        "address": null,
        "birth_date": null,
        "profession": "Avocat",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Thales Brussels SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e donne mandat \u00E0 Madame Anja Seitz, ou les avocats de la soci\u00E9t\u00E9 Thales Brussels SRL, dont Me Alexis Wochenmarkt",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Emmanuel Georgas",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Thales Brussels SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e donne mandat \u00E0 Madame Anja Seitz, ou les avocats de la soci\u00E9t\u00E9 Thales Brussels SRL, dont Me Alexis Wochenmarkt, ou Emmanuel Georgas",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxell",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2026-04-09",
    "filing_date": "2026-02-17",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2026-02-17",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Thales Brussels SRL",
    "person_name": null,
    "org_rep_person_name": "Emmanuel Georgas",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2025
22-09-2025 1 director appointed, 1 resigning Director changes
  • Beryle Zany — Bestuurder
  • Xavier Defourt — Bestuurder
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Xavier Defourt",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "end_of_term",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e constate que le mandat de Monsieur Xavier Defourt, administrateur, est arriv\u00E9 \u00E0 expiration \u00E0 l\u0027issue de la pr\u00E9sente assembl\u00E9e.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Beryle Zany",
        "address": "14 rue du champ de mars 75007 Paris, France",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer, \u00E0 l\u0027unanimit\u00E9, en qualit\u00E9 d\u0027administrateur : Madame Beryle Zany domicili\u00E9e \u00E0 14 rue du champ de mars 75007 Paris, France. Le mandat de Madame Zany sera exerc\u00E9 \u00E0 titre gratuit pour une p\u00E9riode de 6 ans avec effet ce jour.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": 6
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Woluwe-Saint-Lambert",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-09-22",
    "filing_date": "2005-09-15",
    "act_kind_objet": "Nomination - D\u00E9mission"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-06-17",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Emmanuel Georgas",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire special"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
22-09-2025 1 director appointed, 1 resigning Director changes
  • Beryle Zany — Bestuurder
  • Xavier Defourt — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Xavier Defourt",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Beryle Zany",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA"
  }
}
22-09-2025 Beryle Zany appointed as director Director changes
  • Beryle Zany — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Beryle Zany",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-06-17",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer, \u00E0 l\u0027unanimit\u00E9, en qualit\u00E9 d\u0027administrateur : Madame Beryle Zany domicili\u00E9e \u00E0 14 rue du champ de mars 75007 Paris, France. Le mandat de Madame Zany sera exerc\u00E9 \u00E0 titre gratuit pour une p\u00E9riode de 6 ans avec effet ce jour."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
2024
03-09-2024 3 directors appointed Director changes
  • Philippe Dehaspe — Bestuurder
  • Callens Vandelanotte NV — Commissaire
  • Erik Snauwaert — Représentant permanent du commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Philippe Dehaspe",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Callens Vandelanotte NV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Erik Snauwaert",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA"
  }
}
03-09-2024 1 director appointed, 1 reappointed Director changes
  • Erik Snauwaert — Commissaris
  • Philippe Dehaspe — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe Dehaspe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-06-18",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de renouveler \u00E0 l\u0027unanimit\u00E9, avec effet imm\u00E9diat, le mandat d\u0027administrateur de Monsieur Philippe Dehaspe."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Erik Snauwaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Callens Vandelanotte NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Callens Vandelanotte NV, President Kennedypark 1a, 8500 Kortrijk, est nomm\u00E9e en tant que commissaire pour un mandat d\u0027une dur\u00E9e de trois ans."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
03-09-2024 2 directors appointed, 1 resigning, 1 reappointed Director changes
  • Callens Vandelanotte NV — Voorzitter
  • Laury Dormey — Dagelijks bestuur
  • Erik Snauwaert — Commissaris
  • Philippe Dehaspe — Bestuurder
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Philippe Dehaspe",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de renouveler \u00E0 l\u0027unanimit\u00E9, avec effet imm\u00E9diat, le mandat d\u0027administrateur de Monsieur Philippe Dehaspe. Ce mandat sera exerc\u00E9 \u00E0 titre gratuit pour une p\u00E9riode de six ans expirant lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2030.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "voorzitter",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Callens Vandelanotte NV",
        "address": "President Kennedypark 1a, 8500 Kortrijk",
        "country": "BE",
        "legal_form": "NV"
      },
      "statutory": null,
      "compensated": true,
      "effective_date": null,
      "evidence_quote": "Callens Vandelanotte NV, President Kennedypark 1a, 8500 Kortrijk, est nomm\u00E9e en tant que commissaire pour un mandat d\u0027une dur\u00E9e de trois ans. Le mandat expirera au terme de l\u0027assembl\u00E9e g\u00E9n\u00E9rale appel\u00E9e \u00E0 statuer sur les comptes de l\u0027exercice 2026.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2026"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "commissaris_revocation",
      "role": "commissaris",
      "person": {
        "rrn": "A01883",
        "name": "Erik Snauwaert",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Callens Vandelanotte NV",
        "address": "President Kennedypark 1a, 8500 Kortrijk",
        "country": "BE",
        "legal_form": "NV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Callens Vandelanotte NV, d\u00E9signe Monsieur Erik Snauwaert (IRE Nr. A01883), r\u00E9viseur d\u0027entreprises, comme repr\u00E9sentant permanent.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les \u00E9moluments du commissaire pour l\u0027ann\u00E9e comptable se cl\u00F4turant le 31 d\u00E9cembre 2024, sont de 8,100.00 EUR, hors frais et TVA.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Laury Dormey",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Thales Brussels SC/SCRL",
        "address": null,
        "country": "BE",
        "legal_form": "SC/SCRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembi\u00E9e donne mandat \u00E0 Madame Laury Dormey, ou ies avocats de la soci\u00E9t\u00E9 Thales Brussels SC/SCRL, dont Me Alexis Wochenmarkt, ou Emmanuel Georgas chacun pouvant agir seul et avec pouvoir de substitution, pour, le cas \u00E9ch\u00E9ant, effectuer les formalit\u00E9s de publication au Moniteur Belge et pour remp",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-09-03",
    "filing_date": "2024-06-18",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-06-18",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Emmanuel Georgas",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire Sp\u00E9cial"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2023
27-09-2023 Stéphan Mairlot reappointed as director Director changes
  • Stéphan Mairlot — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "St\u00E9phan Mairlot",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-20",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de renouveler \u00E0 l\u0027unanimit\u00E9, avec effet imm\u00E9diat, le mandat d\u0027administrateur de Monsieur St\u00E9phan Mairlot."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
27-09-2023 Stéphan Mairlot appointed as director Director changes
  • Stéphan Mairlot — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "St\u00E9phan Mairlot",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus pharma"
  }
}
23-02-2023 1 director appointed, 1 resigning Director changes
  • Michaël Focant — Commissaris
  • Xavier Nys — Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Xavier Nys",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-01-01",
      "evidence_quote": "L\u0027organe d\u0027administration a pris connaissance du fait que la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL commissaire de Betaplus Pharma SA a d\u00E9cid\u00E9 de remplacer Xavier Nys par Micha\u00EBl Focant, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent avec effet \u00E0 partir de l\u0027exercice clos le 31 d\u00E9ce"
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Micha\u00EBl Focant",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-01-01",
      "evidence_quote": "L\u0027organe d\u0027administration a pris connaissance du fait que la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL commissaire de Betaplus Pharma SA a d\u00E9cid\u00E9 de remplacer Xavier Nys par Micha\u00EBl Focant, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent avec effet \u00E0 partir de l\u0027exercice clos le 31 d\u00E9ce"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
23-02-2023 1 director appointed, 1 resigning Director changes
  • Michaël Focant — Auditor
  • Xavier Nys — Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Micha\u00EBl Focant",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Xavier Nys",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus pharma"
  }
}
23-02-2023 Michaël Focant reappointed as statutory auditor Director changes
  • Michaël Focant — Commissaris
Technical details 
{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Micha\u00EBl Focant",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2022-12-31",
      "evidence_quote": "la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL commissaire de Betaplus Pharma SA a d\u00E9cid\u00E9 de remplacer Xavier Nys par Micha\u00EBl Focant, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent avec effet \u00E0 partir de l\u0027exercice clos le 31 d\u00E9cembre 2022.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2022"
      },
      "rep_rotation_new_rep": "Micha\u00EBl Focant",
      "rep_rotation_old_rep": "Xavier Nys",
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Micha\u00EBl Focant",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-02-23",
    "filing_date": "2022-11-17",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2022-11-17",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Mailys Dessain",
    "org_rep_person_name": null,
    "person_role_at_subject": "Avocat"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
2022
22-09-2022 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
22-09-2022 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2022-01-01",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
03-02-2022 2 directors appointed Director changes
  • Francois Jamar — Bestuurder
  • Xavier Nys — Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Francois Jamar",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-12-03",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9signe comme nouvel administrateur: M. Francois Jamar, domicili\u00E9 rue Virginie Plas 7, 1140 Evere. Son mandat prend effet \u00E0 dater du 3 d\u00E9cembre 2021 et est attribu\u00E9 pour une p\u00E9riode de 6 ans."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Xavier Nys",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027organe d\u0027administration a pris connaissance du fait que la soci\u00E9t\u00E9 KPMG R\u00E9viseurs d\u0027Entreprises BV/SRL commissaire de Betaplus Pharma SA a d\u00E9cid\u00E9 de remplacer Dominic Rousselle par Xavier Nys, r\u00E9viseur d\u0027entreprises, en tant que repr\u00E9sentant permanent avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
03-02-2022 2 directors appointed, 1 resigning Director changes
  • Francois Jamar — Bestuurder
  • Xavier Nys — Représentant permanent du commissaire
  • Dominic Rousselle — Représentant permanent du commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Francois Jamar",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Dominic Rousselle",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Xavier Nys",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus pharma"
  }
}
2021
23-09-2021 3 directors appointed Director changes
  • KPMG Réviseurs d'Entreprises SCRL — Auditor
  • Dominic Rousselle — Auditor representative
  • Benoit Woessmer — Administrator
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "auditor representative",
      "person": {
        "rrn": null,
        "name": "Dominic Rousselle",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus pharma"
  }
}
23-09-2021 2 reappointed Director changes
  • Dominic Rousselle — Commissaris
  • Benoit Woessmer — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Dominic Rousselle",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL (B00001), Luchthaven Brussel Nationaal 1K \u00E0 1930 Zaventem, est nomm\u00E9 en tant que commissaire pour un mandat d\u0027une dur\u00E9e de trois ans."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-04",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renouvelle \u00E0 l\u0027unanimit\u00E9 le mandat d\u0027administrateur de Monsieur Benoit Woessmer compter du 4 mai 2021 pour un terme de quatre ans, prenant fin \u00E0 la date de l\u0027assembl\u00E9e g\u00E9n\u00E9rale approuvant les comptes se cl\u00F4turant le 31.12.2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
03-03-2021 1 director appointed, 2 reappointed Director changes
  • Xavier Defourt — Bestuurder
  • Stéphan Mairlot — Bestuurder
  • Renaud Dehareng — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "St\u00E9phan Mairlot",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-05-07",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renouvelle \u00E0 l\u0027unanimit\u00E9 le mandat d\u0027administrateur de Monsieur St\u00E9phan Mairlot et de Monsieur Renaud Dehareng \u00E0 compter du 7 mai 2019 pour un terme de quatre ans, prenant fin \u00E0 la date de l\u0027assembl\u00E9e g\u00E9n\u00E9rale approuvant les comptes se cl\u00F4turant le 31.12.2022."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Renaud Dehareng",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-05-07",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renouvelle \u00E0 l\u0027unanimit\u00E9 le mandat d\u0027administrateur de Monsieur St\u00E9phan Mairlot et de Monsieur Renaud Dehareng \u00E0 compter du 7 mai 2019 pour un terme de quatre ans, prenant fin \u00E0 la date de l\u0027assembl\u00E9e g\u00E9n\u00E9rale approuvant les comptes se cl\u00F4turant le 31.12.2022."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Xavier Defourt",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-11-27",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer \u00E0 l\u0027unanimit\u00E9, en qualit\u00E9 d\u0027administrateur: Xavier Defourt, domicili\u00E9 \u00E0 1950 Kraainem (Belgique), chauss\u00E9e de Bruxelles 297. Le mandat de Monsieur Xavier Defourt sera exerc\u00E9 \u00E0 titre gratuit pour une p\u00E9riode de quatre ans prenant cours \u00E0 dater du 27 novembre 2020."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
03-03-2021 1 director appointed, 1 resigning Director changes
  • Xavier Defourt — Bestuurder
  • Renaud Dehareng — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Renaud Dehareng",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Xavier Defourt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus pharma"
  }
}
2020
06-11-2020 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BetaPlus Pharma"
  },
  "legal_form_change": {
    "new": "soci\u00E9t\u00E9 anonyme",
    "old": "soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
06-11-2020 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2020-10-21",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
2018
12-12-2018 Dominic Rouselle appointed as statutory auditor Director changes
  • Dominic Rouselle — Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Dominic Rouselle",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG R\u00E9visuers d\u0027Entreprises SCRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "KPMG R\u00E9visuers d\u0027Entreprises SCRL (B00001), Luchthaven Brussel Nationaal 1K \u00E0 1930 Zaventem, est nomm\u00E9 en tant que commissaire pour un mandat d\u0027une dur\u00E9e de trois ans."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
12-12-2018 2 directors appointed Director changes
  • KPMG Réviseurs d'Entreprises SCRL — Commissaire
  • Dominic Rouselle — Représentant permanent du commissaire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Dominic Rouselle",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "Betaplus Pharma"
  }
}
30-05-2018 Publication in the Belgian Official Gazette — Minor change Minor change
Summary: Other address change
Technical details 
{
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2018-05-30",
    "filing_date": "2018-03-09",
    "act_kind_objet": "verbatim"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2018-03-09",
    "unanimous": true
  },
  "agm_change": null,
  "detected_kind": "other_address_change",
  "other_address": {
    "action": "modified",
    "purpose": "statutaire_zetel",
    "address_new": null,
    "address_old": "Avenue Hippocrate n\u00B0 10 1200 Woluwe Saint-Lambert",
    "effective_date": "2018-05-10",
    "effective_date_is_approximate": false
  },
  "mandate_renewal": {
    "period_end": null,
    "mandate_kind": "other",
    "period_start": null,
    "remuneration_eur": null,
    "remuneration_kind": null,
    "person_or_entity_kbo": null,
    "person_or_entity_name": "Me Alexis Wochenmarkt, Me Mailys Dessain, Me Ana\u00EFs De Bi\u00E8vre, Me Rodolphe Horion"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA",
    "legal_form": "SA",
    "_kbo_extracted_mismatch": "0479.037.366"
  },
  "accounts_deposit": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Alexis Wochenmarkt",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "Proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire du 9 mars 2018",
    "Acte de changement de contr\u00F4le conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s"
  ],
  "fiscal_year_change": null,
  "liquidation_closure": null,
  "officer_designation": {
    "role": "other",
    "organ": "raad_van_bestuur",
    "person_name": "Alexis Wochenmarkt"
  },
  "special_procuration": {
    "grantee_kbo": null,
    "grantee_name": "Me Alexis Wochenmarkt, Me Mailys Dessain, Me Ana\u00EFs De Bi\u00E8vre, Me Rodolphe Horion",
    "grantor_name": "BETAPLUS PHARMA",
    "scope_summary": "Mandat sp\u00E9cial pour d\u00E9poser la d\u00E9cision de changement de contr\u00F4le au greffe du Tribunal de Commerce et assurer sa publication au Moniteur Belge.",
    "monetary_cap_eur": null,
    "scope_categories": [
      "publication",
      "legal_filing"
    ],
    "termination_clause": "Le mandat peut \u00EAtre r\u00E9voqu\u00E9 \u00E0 tout moment par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale.",
    "substitution_allowed": true
  },
  "is_volet_a_only_stub": true,
  "vakbekwaamheid_change": {
    "licence_kind": "other",
    "effective_date": null,
    "new_holder_name": null,
    "old_holder_name": null
  },
  "should_reroute_to_category": null,
  "single_shareholder_declaration": null
}
30-05-2018 Publication in the Belgian Official Gazette — Minor change Minor change
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "detected_kind": "special_procuration",
  "effective_date": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  },
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": {
    "quote": "Les Actionnaires donnent mandat \u00E0 Me Alexis Wochenmarkt, Me Mailys Dessain, Me Ana\u00EFs De Bi\u00E8vre et Me Rodolphe Horion du Cabinet d\u0027avocats THALES Avocats (Thales Brussels CVBA) chacun pouvant agir seul et avec facult\u00E9 de substitution, pour, le cas \u00E9ch\u00E9ant, faire tout le n\u00E9cessaire et signer tous les documents aux fins de d\u00E9poser la d\u00E9cision sur base de l\u0027article 556 C. Soc, au greffe du Tribunal de Commerce et d\u0027en assurer la publication au Moniteur Belge et en g\u00E9n\u00E9ral de signer tous documents et remplir toutes formalit\u00E9s n\u00E9cessaires pour ex\u00E9cuter les d\u00E9cisions reprises ci-dessus.",
    "grantee_kbo": null,
    "grantee_name": "Alexis Wochenmarkt, Mailys Dessain, Ana\u00EFs De Bi\u00E8vre, Rodolphe Horion",
    "monetary_cap_eur": null,
    "scope_categories": [
      "KBO",
      "publication"
    ],
    "substitution_allowed": true
  },
  "single_shareholder_declaration": null
}
2016
30-08-2016 Benoit Woessmer reappointed as director Director changes
  • Benoit Woessmer — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-06-08",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renouvelle \u00E0 l\u0027unanimit\u00E9 le mandat d\u0027administrateur de Monsieur Benoit Woessmer \u00E0 compter du 8 Juin 2016 pour un terme de quatre ans, prenant fin \u00E0 la date de l\u0027assembl\u00E9e g\u00E9n\u00E9rale approuvant les comptes se cl\u00F4turant le 31.12.2020."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA, EN ABREGE : BETAPLUS",
    "legal_form": "SA"
  }
}
30-08-2016 Benoit Woessmer appointed as director Director changes
  • Benoit Woessmer — Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Benoit Woessmer",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARMA"
  }
}
2015
24-12-2015 Dominic Rousselle appointed as auditor Director changes
  • Dominic Rousselle — Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Dominic Rousselle",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0479.037.369",
    "name_full": "BETAPLUS PHARM\u0410"
  }
}
First 30 of 37 acts